R, P.; Bashir, S. CRITICAL REVIEW OF PHARMACOGENOMICS IN ANTIPARKINSONIAN DRUG THERAPY: IMPACT ON CLINICAL MANAGEMENT OF PARKINSON’S DISEASE. Asian J Pharm Clin Res 2016, 9, 24-27.